On the basis that receptors with higher expression levels may be more effective targets, this review utilizes bioinformatics approaches to determine the expression profile of purinergic receptors in lung and airway tissue, and explores current evidence implicating specific receptors as potential therapeutic targets for respiratory diseases, with particular reference to asthma. This evidence concerns the gene P2RX3 and asthma.